2509 — Qyuns Therapeutics Share News
0.000.00%
Last trade - 00:00- HK$3.72bn
- HK$3.31bn
- CNY806.96m
Brief: Qyuns Therapeutics Announces Subscription Of Wealth Management Products
Brief: Qyuns Therapeutics Appoints Qiu Jiwan, Wu Yiliang, Lin Weidong As Executive Directors Of Second Session Of Board
Brief: Qyuns Therapeutics Posts HY Loss RMB183.1 Million
Brief: Qyuns Therapeutics Announces Subscription Of Wealth Management Products
Brief: Qyuns Therapeutics Says On June 4, Co Entered Subscription Agreement With ICBC
Brief: Qyuns Therapeutics Co Says Obtained IND Clearance For QX013N